Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
Viruses | Free Full-Text | Direct-Acting Antiviral Agents for Hepatitis C Virus Infection—From Drug Discovery to Successful Implementation in Clinical Practice
Hepatitis C Virus Infection Treatment: Recent Advances and New Paradigms in the Treatment Strategies | IntechOpen
Sofosbuvir, a Significant Paradigm Change in HCV Treatment
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
New perspectives for preventing hepatitis C virus liver graft infection - The Lancet Infectious Diseases
Learning the ABC's of Today's Hepatitis C Medications
Sofosbuvir/Velpatasvir (Epclusa®) Drug Interactions A Quick Guide for Clinicians – February 2019
Antivirals for Hepatitis C | Concise Medical Knowledge
Advances in Treatment of Hepatitis C | IntechOpen
Hepatitis C Treatment in the Era of Direct-Acting Antiviral Agents: Challenges in Developing Countries - ScienceDirect
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Velpatasvir - an overview | ScienceDirect Topics
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Epclusa, INN-sofosbuvir/velpatasvir
Sofosbuvir-Velpatasvir Epclusa - Treatment - Hepatitis C Online
Sofosbuvir/velpatasvir: A promising combination
Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
Epclusa (sofosbuvir + velpatasvir)
Cells | Free Full-Text | Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
